Fred Hutchinson Cancer Center patent applications published on March 21st, 2024
Contents
- 1 Patent applications for Fred Hutchinson Cancer Center on March 21st, 2024
- 1.1 CHIMERIC ANTIGEN RECEPTORS THAT BIND PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA (PRAME)/HLA-A2 TO TREAT CANCER (18454684)
- 1.2 LUTEINIZING HORMONE RECEPTOR BINDING AGENTS AND LUTEINIZING HORMONE AGONISTS TO IDENTIFY, EXPAND, ABLATE AND MODIFY STEM CELLS (18208490)
- 1.3 EPSTEIN BARR VIRUS VACCINES (18458108)
- 1.4 DELTA-LIKE NON-CANONICAL NOTCH LIGAND 1 ACTIVITY MODULATORS AND USES THEREOF (18456339)
- 1.5 SINGLE-DOMAIN ANTIBODIES THAT BIND ROR1 (18350617)
- 1.6 MARKERS, METHODS AND SYSTEMS FOR IDENTIFYING CELL POPULATIONS, DIAGNOSING, MONITORING, PREDICTING AND TREATING CONDITIONS (18509663)
Patent applications for Fred Hutchinson Cancer Center on March 21st, 2024
CHIMERIC ANTIGEN RECEPTORS THAT BIND PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA (PRAME)/HLA-A2 TO TREAT CANCER (18454684)
Main Inventor
Soheil Meshinchi
LUTEINIZING HORMONE RECEPTOR BINDING AGENTS AND LUTEINIZING HORMONE AGONISTS TO IDENTIFY, EXPAND, ABLATE AND MODIFY STEM CELLS (18208490)
Main Inventor
Jarrod Dudakov
EPSTEIN BARR VIRUS VACCINES (18458108)
Main Inventor
Jason Price
DELTA-LIKE NON-CANONICAL NOTCH LIGAND 1 ACTIVITY MODULATORS AND USES THEREOF (18456339)
Main Inventor
Irwin D. Bernstein
SINGLE-DOMAIN ANTIBODIES THAT BIND ROR1 (18350617)
Main Inventor
Jason Price
MARKERS, METHODS AND SYSTEMS FOR IDENTIFYING CELL POPULATIONS, DIAGNOSING, MONITORING, PREDICTING AND TREATING CONDITIONS (18509663)
Main Inventor
Evan Greene
